Cambridge Antibody - Directors' Shareholdings

RNS No 9851k
CAMBRIDGE ANTIBODY TECHNOLOGY
22nd December 1997


Schedule 11 - Notification of interests of Directors and Connected Persons

1   Name of company:
Cambridge Antibody Technology

2   Name of director:
John Aston

3   Please state whether notification indicates that it is in respect of     
holding of the director named in 2 above or holding of that person's spouse or
children under the age of 18 or in respect of a non- beneficial interest:
For Director

4   Name of registered holder(s) and, if more than one holder, the number of 
shares held by each of them (if notified):
 CAT Group Employees' Trustees Limited

5   Please state whether notification relates to a person(s) connected with  
the director named in 2 above and identify the connected person(s):


6   Please state the nature of the transaction. For PEP transactions please  
indicate whether general/single co PEP and if discretionary/non discretionary:
Appropriation of Shares on behalf of Director to Cat Group Employees' Trustees
Limited the Corporate Trustee of an Inland Revenue approved Staff Share Scheme
and a separate grant of options

7   Number of shares/amount of stock acquired:
227

8   Percentage of issued class:


9   Number of shares/amount of stock disposed:


10  Percentage of issued class:
0.001%

11  Class of security:
10p Ordinary Shares

12  Price per share:
 375p

13  Date of transaction:
December 19 1997

14  Date company informed:
December 19 1997

15  Total holding following this notification:
1227

16  Total percentage holding of issued class following this notification:
0.006%

If a director has been granted options by the company, please complete the
following fields:

17  Date of grant:
December 19 1997

18  Period during which or date on which exercisable:
December 19 2000- December 19 2007

19  Total amount paid (if any) for grant of the option:
NIL

20  Description of shares or debentures involved: class, number:
10p Ordinary Shares

21  Exercise price (if fixed at time of grant) or indication that price is to
be fixed at time of exercise:
 500p

22  Total number of shares or debentures over which options held following
this notification:
134000

23  Contact name for queries:
Diane Mellett

24  Contact telephone number:
01763 269245

25  Name of company official responsible for making notification:
Diane Mellett Company Secretary


Schedule 11 - Notification of interests of Directors and Connected Persons

1   Name of company:
Cambridge Antibody Technology

2   Name of director:
David Chiswell

3   Please state whether notification indicates that it is in respect of     
holding of the director named in 2 above or holding of that person's spouse or
children under the age of 18 or in respect of a non- beneficial interest:
For Director

4   Name of registered holder(s) and, if more than one holder, the number of 
shares held by each of them (if notified):
 Cat Group Employees Trustees Limited

5   Please state whether notification relates to a person(s) connected with  
the director named in 2 above and identify the connected person(s):


6   Please state the nature of the transaction. For PEP transactions please  
indicate whether general/single co PEP and if discretionary/non discretionary:
Appropriation of Shares on behalf of Director to Cat Group Employees Trustees
Limited the Corporate Trustee of an Inland Revenue approved Staff Share Scheme


7   Number of shares/amount of stock acquired:
227

8   Percentage of issued class:
0.001%

9   Number of shares/amount of stock disposed:


10  Percentage of issued class:


11  Class of security:
 10p Ordinary Shares

12  Price per share:
375p

13  Date of transaction:
19 December 1997

14  Date company informed:
19 December 1997

15  Total holding following this notification:
250227

16  Total percentage holding of issued class following this notification:
1.129%

If a director has been granted options by the company, please complete the
following fields:

17  Date of grant:


18  Period during which or date on which exercisable:


19  Total amount paid (if any) for grant of the option:


20  Description of shares or debentures involved: class, number:


21  Exercise price (if fixed at time of grant) or indication that price is to
be fixed at time of exercise:


22  Total number of shares or debentures over which options held following
this notification:


23  Contact name for queries:
Diane Mellett

24  Contact telephone number:
01763 269 245

25  Name of company official responsible for making notification:
Diane Mellett Company Secretary


Schedule 11 - Notification of interests of Directors and Connected Persons

1   Name of company:
Cambridge Antibody Technology

2   Name of director:
David Glover

3   Please state whether notification indicates that it is in respect of     
holding of the director named in 2 above or holding of that person's spouse or
children under the age of 18 or in respect of a non- beneficial interest:
Director

4   Name of registered holder(s) and, if more than one holder, the number of 
shares held by each of them (if notified):
CAT Group Employees Trustees Limited

5   Please state whether notification relates to a person(s) connected with  
the director named in 2 above and identify the connected person(s):


6   Please state the nature of the transaction. For PEP transactions please  
indicate whether general/single co PEP and if discretionary/non discretionary:
Appropriation of Shares on behalf of Director to Cat Group Employees Trustees
Limited  the Corporate Trustee of an an Inland Revenue approved Staff Share
Scheme and a separate grant of options

7   Number of shares/amount of stock acquired:
227

8   Percentage of issued class:
0.001%

9   Number of shares/amount of stock disposed:


10  Percentage of issued class:


11  Class of security:
10p Ordinary Shares

12  Price per share:
375p

13  Date of transaction:
December 19 1997

14  Date company informed:
December 19 1997

15  Total holding following this notification:
6427

16  Total percentage holding of issued class following this notification:
0.029%

If a director has been granted options by the company, please complete the
following fields:

17  Date of grant:
December 19 1997

18  Period during which or date on which exercisable:
December 19 2000- December 19 2007

19  Total amount paid (if any) for grant of the option:
Nil

20  Description of shares or debentures involved: class, number:
10p Ordinary Shares

21  Exercise price (if fixed at time of grant) or indication that price is to
be fixed at time of exercise:
500p

22  Total number of shares or debentures over which options held following
this notification:
90,000

23  Contact name for queries:
Diane Mellett

24  Contact telephone number:
01763 269245

25  Name of company official responsible for making notification:
Diane Mellett Company Secretary


Schedule 11 - Notification of interests of Directors and Connected Persons

1   Name of company:
Cambridge Antibody Technology

2   Name of director:
Kevin Johnson

3   Please state whether notification indicates that it is in respect of     
holding of the director named in 2 above or holding of that person's spouse or
children under the age of 18 or in respect of a non- beneficial interest:
For Director

4   Name of registered holder(s) and, if more than one holder, the number of 
shares held by each of them (if notified):
Cat Group Employees' Trustees Limited

5   Please state whether notification relates to a person(s) connected with  
the director named in 2 above and identify the connected person(s):


6   Please state the nature of the transaction. For PEP transactions please  
indicate whether general/single co PEP and if discretionary/non discretionary:
Appropriation of Shares on behalf of Director to Cat Group Employees' Trustees
Limited the Corporate Trustee of an Inland Revenue approved Staff Share Scheme
and a separate grant of options

7   Number of shares/amount of stock acquired:
227

8   Percentage of issued class:
0.001%

9   Number of shares/amount of stock disposed:


10  Percentage of issued class:


11  Class of security:
 10p Ordinary Shares

12  Price per share:
375p

13  Date of transaction:
19 December 1997

14  Date company informed:
19 December 1997

15  Total holding following this notification:
227

16  Total percentage holding of issued class following this notification:
0.001%

If a director has been granted options by the company, please complete the
following fields:

17  Date of grant:
19 December 1997

18  Period during which or date on which exercisable:
19 December 2000- 19 December 2007

19  Total amount paid (if any) for grant of the option:
Nil

20  Description of shares or debentures involved: class, number:
 10p Ordinary Shares

21  Exercise price (if fixed at time of grant) or indication that price is to
be fixed at time of exercise:
500p

22  Total number of shares or debentures over which options held following
this notification:
152,500

23  Contact name for queries:
Diane Mellett

24  Contact telephone number:
01763 269 245

25  Name of company official responsible for making notification:
Diane Mellett Company Secretary


END

RDAOCBCBBDDDPBB